NCT00871936View on ClinicalTrials.gov

A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Type 2 Diabetes
Interventions
DRUG

SLx-4090

SLx-4090

OTHER

Placebo

matching tablets

DRUG

Metformin

Trial Locations (12)

27103

Winston-Salem

28211

Charlotte

28602

Hickory

29615

Greenville

33401

West Palm Beach

60101

Addison

78229

San Antonio

90036

Los Angeles

90057

Los Angeles

91505

Burbank

92801

Anaheim

04210

Auburn

Sponsors
All Listed Sponsors
lead

Response Pharmaceuticals

INDUSTRY

NCT00871936 - A Comparison of SLx-4090 in Combination With Metformin Versus Metformin Therapy Alone in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter